Evaluation of Paclitaxel as a Non-Cross-Resistant Agent in Cisplatin-Resistant Small Cell Lung Cancer (SCLC). International Cancer Research Journal, [S. l.], v. 1, n. 1, p. 2, 2025. DOI: 10.70844/icrj.2025.1.2. Disponível em: https://icrj.meteorpub.com/1/article/view/7. Acesso em: 6 feb. 2026.